Use of Low Doses of Interleukin-2 in Autism Spectrum Disorders
NCT07589842
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Autism Spectrum Disorder
Interventions
DRUG:
ILT-101 ld-(IL2)
DRUG:
NaCl (0,9%)
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
[object Object]